Skip to main content
Calian Group Ltd. logo

Calian Group Ltd. — Investor Relations & Filings

Ticker · CGY ISIN · CA12989J1084 LEI · 894500ROTOK2S8REKR46 TSX Professional, scientific and technical activities
Open in API
Filings indexed 199 across all filing types
Latest filing 2020-08-11 Interim / Quarterly Rep…
Country CA Canada
Listing TSX CGY

About Calian Group Ltd.

https://www.calian.com/

Calian Group Ltd. delivers specialized, mission-critical business services and solutions across diverse markets. The company operates through four primary segments: Advanced Technologies, Health, Learning, and IT & Cyber Solutions. The Advanced Technologies segment supplies highly technical products and services globally. The Health segment focuses on comprehensive health services, while Learning delivers specialized training and simulation solutions. IT & Cyber Solutions provides cybersecurity, cloud integration, and managed IT services. Calian emphasizes innovation by integrating AI into its mission-critical solutions, leveraging deep subject matter expertise to enable smarter decisions, streamline processes, and ensure operational excellence for its clients.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Interim / Quarterly Report Classification · 100% confidence The document is a detailed quarterly financial report for Calian Group Ltd. covering the three-month period ended June 30, 2020. It includes comprehensive financial data such as revenue, EBITDA, net profit, segment performance, contract signings, acquisitions, and guidance for the next quarter. It also contains unaudited interim condensed consolidated financial statements with detailed asset and liability breakdowns. The presence of actual financial statements and substantive financial data for a period shorter than a full fiscal year clearly identifies this as an Interim / Quarterly Report. The document is about 15,000 characters long, which is consistent with a full report rather than a brief announcement or press release. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2020-08-11 English
Interim MD&A - English.pdf
Regulatory Filings
2020-08-11 English
52-109F2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 95% confidence The document is a certification by the CEO of Calian Group Ltd regarding the interim financial statements and interim MD&A for the period ended June 30, 2020. It references National Instrument 52-109, which relates to certification of disclosure in issuers' annual and interim filings. The content is primarily an officer certification attesting to the accuracy and fairness of the interim filings, controls, and procedures, without containing actual financial data or substantive financial analysis. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is 3379 characters, which is relatively short and consistent with a certification letter rather than a full interim report.
2020-08-11 English
52-109F2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 100% confidence The document is a certification by the Chief Financial Officer regarding the interim financial statements and interim MD&A for the period ended June 30, 2020. It is a Form 52-109F2 certification, which is a regulatory attestation of the accuracy and completeness of interim filings. The document does not contain the actual interim financial statements or substantive financial data but rather certifies their review and fairness. According to the Certification Rule, such officer certifications should be classified as Regulatory Filings (RNS) rather than as the interim report itself (IR). The document length is short (3394 characters), and it is clearly a certification letter, not the full interim report.
2020-08-11 English
Interim financial statements/report – English.pdf
Regulatory Filings
2020-08-11 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the commercial release of a new product, the Decimator D4 spectrum analyzer, by Calian Group Ltd. It contains no financial data, no regulatory filing references, no meeting or voting information, no management or board changes, no earnings or interim report data, and no legal or merger-related content. It is a product launch announcement aimed at investors and the public, focusing on product features and company strategy. This type of document does not fit into any of the specific financial or regulatory filing categories such as Annual Report, Earnings Release, or Investor Presentation. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement or press release that does not fit other categories.
2020-06-16 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.